Evidence map›Paper›PMID 35881259›Full record

ArticleJapanese journal of radiology2022

Association of severe COVID-19 outcomes with radiological scoring and cardiomegaly: findings from the COVID-19 inpatients database, Japan.

Atsuhiro Kanayama, Yuuki Tsuchihashi, Yoichi Otomi, Hideaki Enomoto, Yuzo Arima, Takuri Takahashi, Yusuke Kobayashi, Koki Kaku, Tomimasa Sunagawa, Motoi Suzuki and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Japanese journal of radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Atsuhiro KanayamaCenter for Field Epidemic Intelligence, Research, and Professional Development, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
Yuuki TsuchihashiCenter for Field Epidemic Intelligence, Research, and Professional Development, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan. yuuki@niid.go.jp.ORCID http://orcid.org/0000-0002-6117-4448
Yoichi OtomiDepartment of Radiology, Tokushima University Hospital, 2-50-1 Kuramoto, Tokushima-city, Tokushima, 770-8503, Japan.
Hideaki EnomotoDepartment of Radiology, Tokushima University Hospital, 2-50-1 Kuramoto, Tokushima-city, Tokushima, 770-8503, Japan.
Yuzo ArimaCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
Takuri TakahashiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
Yusuke KobayashiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
Koki KakuDivision of Infectious Diseases Epidemiology and Control, National Defense Medical College Research Institute, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Tomimasa SunagawaCenter for Field Epidemic Intelligence, Research, and Professional Development, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
Motoi SuzukiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
COVID-19 discharge summary database (CDSD) group
National Institute of Infectious Diseases · JPTokushima University Hospital · JPNational Defense Medical College · JP

Funding

Ministry of Health, Labour and Welfare 21HA1004Ministry of Health, Labour and Welfare 21HA2015
6 · The paper itself

Abstract

purposeWe aimed to characterize novel coronavirus infections based on imaging [chest X-ray and chest computed tomography (CT)] at the time of admission. MATERIALS AND

methodsWe extracted data from 396 patients with laboratory-confirmed COVID-19 who were managed at 68 hospitals in Japan from January 25 to September 2, 2020. Case patients were categorized as severe (death or treatment with invasive ventilation during hospitalization) and non-severe groups. The imaging findings of the groups were compared by calculating odds ratios (ORs) and 95% confidence intervals (95% CIs), adjusted for sex, age, and hospital size (and radiographic patient positioning for cardiomegaly). Chest X-ray and CT scores ranged from 0 to 72 and 0 to 20, respectively. Optimal cut-off values for these scores were determined by a receiver-operating characteristic (ROC) curve analysis.

resultsThe median age of the 396 patients was 48 years (interquartile range 28-65) and 211 (53.3%) patients were male. Thirty-two severe cases were compared to 364 non-severe cases. At the time of admission, abnormal lesions on chest X-ray and CT were mainly observed in the lower zone/lobe. Among severe cases, abnormal lesions were also seen in the upper zone/lobe. After adjustment, the total chest X-ray and CT score values showed a dose-dependent association with severe disease. For chest X-ray scores, the area under the ROC curve (AUC) was 0.91 (95% CI = 0.86-0.97) and an optimal cut-off value of 9 points predicted severe disease with 83.3% sensitivity and 84.7% specificity. For chest CT scores, the AUC was 0.94 (95% CI = 0.89-0.98) and an optimal cut-off value of 11 points predicted severe disease with 90.9% sensitivity and 82.2% specificity. Cardiomegaly was strongly associated with severe disease [adjusted OR = 24.6 (95% CI = 3.7-166.0)].

conclusionChest CT and X-ray scores and the identification of cardiomegaly could be useful for classifying severe COVID-19 on admission.

Indexed as

COVID-19CardiomegalyFemaleHumansInpatientsJapanMaleMiddle AgedRetrospective StudiesSARS-CoV-2CardiomegalyChest CT scoresChest X-ray scoresCOVID-19Severity

Identifiers

PMID35881259
PMCPMC9315080
OpenAlexW4288042125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.